Skip to content
Catalyst

lactoferrinFinding

Lactoferrin decreases hospital length of stay

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Meta-analysis of data from twelve randomized controlled trials showed that lactoferrin supplementation to enteral feeds decreased late-onset sepsis (typical RR 0.82, 95% CI 0.74 to 0.91; typical RD -0.04, 95% CI, -0.06, -0.02; NNTB 25, 95% CI 17 to 50; 12 studies, 5425 participants, low-certainty evidence) and decreased length of hospital stay (MD -2.38, 95% CI, -4.67, -0.09; 3 studies, 1079 participants, low-certainty evidence).”
Quoted verbatim from Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
This finding among the 36 findings on its endpoint

lactoferrin

Hospital length of stay

lowers

Effect as reported

−2.38mean difference

CI −4.67 to −0.09

Who
n = 1,079 · preterm neonates in hospital, lactoferrin added to enteral feeds; length of stay to discharge (3 trials pooled)
Dose studied
not reported

Very limited evidencePMID 32232984 · 2020

02 · The study

Study
meta-analysis
Participants
1,079
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7MA15AK2QAJ9ETXXBJ14YMP